Neracorvir

奈瑞可韦

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameNeracorvir
Drug Alias NameGST-HG141
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein modulators
TargetsCapsid protein
Therapy Area/IndicationsHepatitis, Viral, HumanHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesFujian Cosunter Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFujian Guangsheng Zhonglin Biotechnology Co LtdFujian Cosunter Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis, Viral, HumanHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A